A phase II study of JS001, a humanized PD-1 mAb, in patients with advanced melanoma in China

作者:Chi, Zhihong; Tang, Bixia; Sheng, Xinan; Si, Lu; Cui, Chuanliang; Kong, Yan; Chen, Yingbo; Qin, Shukui; Chen, Jing; Wu, Di; Song, Xin; Yan, Xieqiao; Yu, Jiayi; Guo, Jun
DOI:10.1200/JCO.2018.36.15_suppl.9539

全文